Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Common Shares and Warrants (Details)	3 Months Ended
Common Shares and Warrants (Details)	Nov. 30, 2023 $ / shares shares
Common Shares and Warrants
Number of Warrants, Beginning Balance \| shares	4,520,483
Number of Warrants, Issued \| shares	2,347,388
Number of Warrants, Exercised \| shares	(1,330,719)
Number of Warrants, Ending Balance \| shares	5,537,152
Weighted Average Exercise Price, Beginning Balance \| $ / shares	$ 4.71
Weighted Average Exercise Price, Issued \| $ / shares	0.65
Weighted Average Exercise Price, Exercised \| $ / shares	0.43
Weighted Average Exercise Price, Ending Balances \| $ / shares	$ 4.02